Kodiak Sciences (KOD) Interest & Investment Income (2018 - 2026)
Kodiak Sciences' (KOD) quarterly Interest & Investment Income came in at $1.6 million in Q1 2026, up 2.43% YoY from $1.6 million in Q1 2025, and up 116.78% on a QoQ basis from $757000.0 in Q4 2025.
Analysis
Kodiak Sciences (KOD) Interest & Investment Income (2018 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 9 years of Interest & Investment Income data on file, last reported at $1.6 million in Q1 2026.
- Quarterly Interest & Investment Income rose 2.43% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (down 51.52% YoY) and the FY2025 annual result came in at $4.5 million, down 59.48% from the prior year.
- Interest & Investment Income advanced to $1.6 million in Q1 2026, from $757000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $4.7 million in Q2 2023 to a low of $76000.0 in Q1 2022.
- A 5-year average of $2.4 million and a median of $2.5 million in 2022 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income soared 10675.0% — and 2025, when it slumped 66.17%.
- Tracing KOD's Interest & Investment Income over 5 years: stood at $3.0 million in 2022, then advanced by 29.17% to $3.9 million in 2023, then slumped by 45.34% to $2.1 million in 2024, then plunged by 64.46% to $757000.0 in 2025, then surged by 116.78% to $1.6 million in 2026.
- The last three Interest & Investment Income figures came in at $1.6 million (Q1 2026), $757000.0 (Q4 2025), and $917000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Kodiak Sciences | 2.21 Bn | 2.21 Bn | - | 1.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.26 Mn |
| Mar 31, 2026 | 1.64 Mn |
| Dec 31, 2025 | 757,000.00 |
| Sep 30, 2025 | 917,000.00 |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 2.95 Mn |
| Mar 31, 2024 | 3.35 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Sep 30, 2023 | 4.54 Mn |
| Jun 30, 2023 | 4.68 Mn |
| Mar 31, 2023 | 3.62 Mn |
| Dec 31, 2022 | 3.02 Mn |
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | 1.49 Mn |
| Mar 31, 2022 | 76,000.00 |
| Dec 31, 2021 | 28,000.00 |
| Sep 30, 2021 | 40,000.00 |